Rasna Therapeutics, Inc. (RASP)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8516.00 | -312.66 Thousand | -293.39 Thousand | -251.32 Thousand | -92.62 Thousand | -2.62 Million |
| Net Income | -4.44 Million | -686.58 Thousand | -785.08 Thousand | -5.34 Million | -936.38 Thousand | -4.07 Million |
| Depreciation & Amortization | - | - | 314.00 | 1635.00 | 3471.00 | 4833.00 |
| Deferred income taxes | - | - | -90.91 Thousand | -3034.00 | -7584.00 | 2093.00 |
| Stock-based compensation | 3.85 Million | - | 42.67 Thousand | 134.63 Thousand | 368.07 Thousand | 621.93 Thousand |
| Change in working capital | 371.1 Thousand | 71.25 Thousand | -123.68 Thousand | 48.32 Thousand | 452.22 Thousand | 264.08 Thousand |
| Other non-cash items | 4.05 Million | 302.67 Thousand | 663.29 Thousand | 4.91 Million | 27.56 Thousand | 553.62 Thousand |
| Investing Cash Flow | - | - | - | - | - | -4073.00 |
| Investments in PPE | - | - | - | - | - | -4073.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 44.13 Thousand | 341.17 Thousand | 290 Thousand | 215.5 Thousand | 100 Thousand | 135 Thousand |
| Debt repayment | -44.13 Thousand | -68.82 Thousand | -290 Thousand | -215.5 Thousand | -100 Thousand | -135 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.85 Million | - | - | - | - | - |
| Other Financing Activities | 44.13 Thousand | 410 Thousand | 290 Thousand | 215.5 Thousand | 100 Thousand | 135 Thousand |
| Accounts receivables | - | - | 748.00 | 2512.00 | 283.29 Thousand | -175.64 Thousand |
| Accounts payables | 106.89 Thousand | -14.68 Thousand | -119.78 Thousand | 45.19 Thousand | 168.93 Thousand | 439.72 Thousand |
| Inventory | - | - | -748.00 | -2512.00 | -283.29 Thousand | - |
| Other working capital | 264.21 Thousand | 85.93 Thousand | -3894.00 | 3124.00 | 283.29 Thousand | -175.64 Thousand |
| Cash at beginning of period | 39.36 Thousand | 10.84 Thousand | 14.24 Thousand | 50.06 Thousand | 42.69 Thousand | 2.53 Million |
| Cash at end of period | 74.98 Thousand | 39.36 Thousand | 10.84 Thousand | 14.24 Thousand | 50.06 Thousand | 42.69 Thousand |
| Capital Expenditure | - | - | - | - | - | -4073.00 |
| Effect of forex changes on cash | - | - | - | - | - | 3955.00 |
| Net cash flow / Change in cash | 35.62 Thousand | 28.51 Thousand | -3393.00 | -35.82 Thousand | 7375.00 | -2.49 Million |
| Free Cash Flow | -8516.00 | -312.66 Thousand | -293.39 Thousand | -251.32 Thousand | -92.62 Thousand | -2.63 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -95.51 Thousand | -147.63 Thousand | -58.32 Thousand | -4.44 Million | -105.16 Thousand | -4.12 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 3.85 Million | - | 3.85 Million |
| Change in working capital | 36.43 Thousand | 77.51 Thousand | 56.06 Thousand | 371.1 Thousand | 110.31 Thousand | 83.89 Thousand |
| Other non-cash items | 22.87 Thousand | 22.82 Thousand | 8940.97 | 4.05 Million | 4840.00 | 4.01 Million |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 18.04 Thousand | -8509.00 | 65.86 Thousand | 44.13 Thousand | -9736.00 | -21.56 Thousand |
| Debt repayment | -18.04 Thousand | -8509.00 | -65.86 Thousand | -44.13 Thousand | -9736.00 | -21.56 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | -205.91 Million | 3.85 Million | - | - |
| Other Financing Activities | 18 Thousand | -8509.00 | 65.86 Thousand | 44.13 Thousand | -9736.00 | -21.56 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -10.15 Thousand | 55.6 Thousand | -23.41 Thousand | 106.89 Thousand | 16.37 Thousand | 27.97 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 36.43 Thousand | 21.91 Thousand | 79.47 Thousand | 264.21 Thousand | 93.93 Thousand | 55.91 Thousand |
| Cash at beginning of period | 19.18 Thousand | 74.98 Thousand | 2472.00 | 39.36 Thousand | 2221.00 | 47.55 Thousand |
| Cash at end of period | 1392.00 | 19.18 Thousand | 74.98 Thousand | 74.98 Thousand | 2472.00 | 2221.00 |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -17.79 Thousand | -55.8 Thousand | 72.51 Thousand | 35.62 Thousand | 251.00 | -45.33 Thousand |
| Free Cash Flow | -36.2 Thousand | -47.29 Thousand | 6676.97 | -8516.00 | 9987.00 | -23.76 Thousand |
6080
POONAWALLA
MODIRUBBER
3PLAND
1086
ITMC